XLRN Crosses Above Average Analyst Target

In recent trading, shares of Acceleron Pharma, Inc. (XLRN) have crossed above the average analyst 12-month target price of $179.30, changing hands for $179.68/share..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.